NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

One possibility here about the publication is that a better offer from the journal was accepted to provide more highlight to the article and they agreed to wait another month or two to take advantage

You do realize that with the interim report they could not find a single respectable journal to publish it. They ended up having to pay to have the article published in the Journal of Translational Medicine or whatever it was called. They paid to have it published on short turnaround with no peer review.

To assume this delay is the result of their accepting a "better offer" for publication is beyond absurd. In fact, this whole wait has nothing to do with publication. How could anyone justify letting cancer patients die while they waited for just the right publication? Seriously? Why the hell can't they just release the TLD, or pay to have it published in the JTM again? Isn't the whole point of this to save patients' lives? This is so dumb, and anyone who believes the publication ruse is utterly delusional. The only possible explanation is that the data is not good and there is no publication willing to put this sham, with its post-facto endpoint changes and reliance on historical comparisons, in print.